Overview
Mei Kong practices practicing medicine in China.
Her clinical expertise encompasses PIK3CA-Related Overgrowth Spectrum, Solitary Fibrous Tumor, Stomach Cancer, and Hemangioma.
She is actively involved in clinical research, co-authoring 34 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Mei S. Kong
Is Mei S. Kong a top-rated expert for PIK3CA-Related Overgrowth Spectrum?
MediFind is an objective health platform that identifies experts based on real-world data. Mei S. Kong is classified as an Experienced expert for PIK3CA-Related Overgrowth Spectrum, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Mei S. Kong participate in research or clinical trials?
Yes. Mei S. Kong has published 34 articles and abstracts on conditions like PIK3CA-Related Overgrowth Spectrum. You can view a list of Mei S. Kong's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- FibrosarcomaMs. Kong isExperienced. Learn about Fibrosarcoma.
- HemangiomaMs. Kong isExperienced. Learn about Hemangioma.
- Lung CancerMs. Kong isExperienced. Learn about Lung Cancer.
- Malignant Peripheral Nerve Sheath Tumor
- Non-Small Cell Lung Cancer (NSCLC)Ms. Kong isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).
- PIK3CA-Related Overgrowth SpectrumMs. Kong isExperienced. Learn about PIK3CA-Related Overgrowth Spectrum.
- Salivary Gland TumorsMs. Kong isExperienced. Learn about Salivary Gland Tumors.
- Solitary Fibrous TumorMs. Kong isExperienced. Learn about Solitary Fibrous Tumor.
- Stomach CancerMs. Kong isExperienced. Learn about Stomach Cancer.